XML 25 R10.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Cash and Marketable Securities | 12 Months Ended
--- | ---
Dec. 31, 2017
Cash and Cash Equivalents [Abstract] |
Cash and Marketable Securities | Cash and Marketable Securities: The components of our investments as of December 31, 2017 are as follows (in millions):
| Cash & Cash Equivalents |  | Restricted Cash |  | Restricted Marketable Securities |  | Total
Cash | $ | 54.4 |  |  | $ | 62.4 |  |  | $ | — |  |  | $ | 116.8 |
Equity securities | — |  |  | — |  |  | 62.0 |  |  | 62.0 |
Total | $ | 54.4 |  |  | $ | 62.4 |  |  | $ | 62.0 |  |  | $ | 178.8 |
The components of our investments as of December 31, 2016 are as follows (in millions):
| Cash & Cash Equivalents |  | Restricted Cash |  | Restricted Marketable Securities |  | Total
Cash | $ | 40.5 |  |  | $ | 60.9 |  |  | $ | — |  |  | $ | 101.4 |
Equity securities | — |  |  | — |  |  | 57.7 |  |  | 57.7 |
Total | $ | 40.5 |  |  | $ | 60.9 |  |  | $ | 57.7 |  |  | $ | 159.1 |
Restricted Cash— As of December 31, 2017 and 2016, Restricted cash consisted of the following (in millions):
| As of December 31,
| 2017 |  | 2016
Affiliate cash | $ | 18.1 |  |  | $ | 22.9 |
Self-insured captive funds | 44.3 |  |  | 38.0 |
Total restricted cash | $ | 62.4 |  |  | $ | 60.9 |
Affiliate cash represents cash accounts maintained by joint ventures in which we participate where one or more of our external partners requested, and we agreed, that the joint venture’s cash not be commingled with other corporate cash accounts and be used only to fund the operations of those joint ventures. Self-insured captive funds represent cash held at our wholly owned insurance captive, HCS, Ltd., as discussed in Note 10, Self-Insured Risks. These funds are committed to pay third-party administrators for claims incurred and are restricted by insurance regulations and requirements. These funds cannot be used for purposes outside HCS without the permission of the Cayman Islands Monetary Authority. The classification of restricted cash held by HCS as current or noncurrent depends on the classification of the corresponding claims liability. As of December 31, 2017 and 2016, all restricted cash was current. Marketable Securities— Restricted marketable securities at both balance sheet dates represent restricted assets held at HCS. HCS insures a substantial portion Encompass Health’s professional liability, workers’ compensation, and other insurance claims. These funds are committed for payment of claims incurred, and the classification of these marketable securities as current or noncurrent depends on the classification of the corresponding claims liability. As of December 31, 2017 and 2016, $44.2 million and $33.5 million, respectively, of restricted marketable securities are included in Other long-term assets in our consolidated balance sheets. A summary of our restricted marketable securities as of December 31, 2017 is as follows (in millions):
| Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value
Equity securities | $ | 64.0 |  |  | $ | 0.3 |  |  | $ | (2.3 | ) |  | $ | 62.0 |
A summary of our restricted marketable securities as of December 31, 2016 is as follows (in millions):
| Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value
Equity securities | $ | 59.6 |  |  | $ | 0.2 |  |  | $ | (2.1 | ) |  | $ | 57.7 |
Cost in the above tables includes adjustments made to the cost basis of our equity securities for other-than-temporary impairments. During the years ended December 31, 2017, 2016, and 2015, we did not record any impairment charges related to our restricted marketable securities. Investing information related to our restricted marketable securities is as follows (in millions):
| For the Year Ended December 31,
| 2017 |  | 2016 |  | 2015
Proceeds from sales of restricted available-for-sale securities | $ | 4.0 |  |  | $ | — |  |  | $ | — |
Proceeds from sales of nonrestricted available-for-sale securities | $ | — |  |  | $ | — |  |  | $ | 12.8 |
Gross realized gains | $ | — |  |  | $ | — |  |  | $ | 1.2 |
Gross realized losses | $ | — |  |  | $ | — |  |  | $ | — |
Our portfolio of marketable securities is comprised of investments in mutual funds that hold investments in a variety of industries and geographies. As discussed in Note 1, Summary of Significant Accounting Policies, “Marketable Securities,” when our portfolio includes marketable securities with unrealized losses that are not deemed to be other-than-temporarily impaired, we examine the severity and duration of the impairments in relation to the cost of the individual investments. We also consider the industry and geography in which each investment is held and the near-term prospects for a recovery in each.

X
- References No definition available. + Details
Name: | us-gaap_CashAndCashEquivalentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 305 -URI http://asc.fasb.org/topic&trid=2122426 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 + Details
Name: | us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration